Join to View Full Profile
11100 Euclid AveCleveland, OH 44106
Phone+1 216-844-7494
Fax+1 216-383-6749
Are you Dr. Willis?
Join over one million U.S. Physicians, Nurse Practitioners and PAs, already on Doximity.
- Gain access to free telehealth tools, such as our "call shielding" and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Summary
- Dr. Joseph Willis, MD is a board certified pathologist in Cleveland, Ohio. He is currently licensed to practice medicine in Ohio and Michigan. He is an Associate Professor at Case Western Reserve University.
Education & Training
University of RochesterResidency, Pathology-Anatomic and Clinical, 1988 - 1992
University College Cork Faculty of MedicineClass of 1982
Certifications & Licensure
OH State Medical License 1993 - 2025
MI State Medical License 1992 - 1996
American Board of Pathology Anatomic Pathology & Clinical Pathology- American Board of Pathology Cytopathology
Publications & Presentations
PubMed
- Association between dietary fructose and human colon DNA methylation: implication for racial disparities in colorectal cancer risk using a cross-sectional study.Matthew A Devall, Stephen Eaton, Gaizun Hu, Xiangqing Sun, Ethan Jakum
The American Journal of Clinical Nutrition. 2025-03-01 - 1 citationsLeucine-Rich Alpha-2-Glycoprotein 1 Promotes Metastatic Colorectal Cancer Growth Through Human Epidermal Growth Factor Receptor 3 Signaling.Moeez Rathore, Kimberly Curry, Wei Huang, Michel'le Wright, Daniel Martin
Gastroenterology. 2025-02-01 - 2 citationsMulticenter, Prospective Trial of Nonendoscopic Biomarker-Driven Detection of Barrett's Esophagus and Esophageal Adenocarcinoma.Helen R Moinova, Suman Verma, John Dumot, Ashley Faulx, Prasad G Iyer
The American Journal of Gastroenterology. 2024-11-01
Press Mentions
Medical Device Developed by CWRU/UH Researchers Wins 2020 Edison AwardMay 8th, 2020
Swallowable Device to Detect Barrett's Esophagus Receives FDA 510(K) ClearanceSeptember 5th, 2019
PAVmed and Case Western Reserve University Finalize Definitive Licensing Agreement for Groundbreaking EsoCheck TechnologyMay 15th, 2018- Join now to see all
Grant Support
- A Clinical Trial of Cancer Prevention by Biomarker Based Detections of Barrett's Esophagus and Its ProgressionCASE WESTERN RESERVE UNIVERSITY2025–2029
- Validation of Biomarkers for predicting Barrett's esophagus that will or will not: i) progress towards cancer, or ii) recur after ablationCASE WESTERN RESERVE UNIVERSITY2022–2027
